Overview 

This competitive grant program seeks to support research studies that focus on generating evidence on the use of elranatamab in multiple myeloma in the real world setting. 

Geographic Scope 

Global Project Types and Area of Interest 

Projects that will be considered for Pfizer support will focus on: 

• Safety and efficacy of elranatamab in the context of real-world use 

• Outpatient administration of elranatamab and alternative CRS/ICANS mitigation strategies 

• Impact of prior treatments (BsAb, CAR-T, ADC) on elranatamab outcomes, and wash-out period between treatments 

• Infection patterns, timing, types, and management strategies including Ig replacement therapy 

• Identifying clinical and biological features of refractoriness, early- or late